Published in Obesity and Diabetes Week, August 23rd, 2004
Founded by John McMichael, PhD, the institute is a not-for-profit organization specializing in discovery and early-stage development of therapeutic agents for chronic diseases. The principal features of these agents are that they are derived from naturally occurring molecules, and that they are administered in low doses.
This profile offers a substantial cost savings in terms of research, development, manufacturing, and time. In addition, to date these agents have produced very few, and only minor, adverse...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.